Skip to main content
. 2014 Jul;35(7):1263–1269. doi: 10.3174/ajnr.A3990

Table 2:

Percentage correct with the model when applied to the discovery cohort and validation cohort

Medulloblastoma Subgroups Percentage Correct in Discovery Cohort Percentage Correct in Validation Cohort
Total 66% 65%
    WNT 75% 50%
    SHH 54% 73%
    Group 3 92% 83%
    Group 4 59% 58%